189 related articles for article (PubMed ID: 19789031)
21. Regulation of CDX2 expression in esophageal adenocarcinoma.
Vaninetti N; Williams L; Geldenhuys L; Porter GA; Guernsey DL; Casson AG
Mol Carcinog; 2009 Oct; 48(10):965-74. PubMed ID: 19415720
[TBL] [Abstract][Full Text] [Related]
22. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
Souza RF
J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
[TBL] [Abstract][Full Text] [Related]
23. Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibition.
Menke V; van Es JH; de Lau W; van den Born M; Kuipers EJ; Siersema PD; de Bruin RW; Kusters JG; Clevers H
Dis Model Mech; 2010; 3(1-2):104-10. PubMed ID: 20075383
[TBL] [Abstract][Full Text] [Related]
24. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
Souza RF; Krishnan K; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
[TBL] [Abstract][Full Text] [Related]
25. Roles of Kruppel-like factor 4 in oesophageal epithelial cells in Barrett's epithelium development.
Kazumori H; Ishihara S; Takahashi Y; Amano Y; Kinoshita Y
Gut; 2011 May; 60(5):608-17. PubMed ID: 21193454
[TBL] [Abstract][Full Text] [Related]
26. Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2.
Shen C; Zhang H; Wang P; Feng J; Li J; Xu Y; Zhang A; Shao S; Yu X; Yan W; Xia Y; Hu J; Fang D
Cell Cycle; 2016 Jun; 15(11):1439-49. PubMed ID: 27096226
[TBL] [Abstract][Full Text] [Related]
27. Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes.
Marchetti M; Caliot E; Pringault E
J Cell Sci; 2003 Apr; 116(Pt 8):1429-36. PubMed ID: 12640028
[TBL] [Abstract][Full Text] [Related]
28. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
29. The role of Cdx2 in Barrett's metaplasia.
Colleypriest BJ; Farrant JM; Slack JM; Tosh D
Biochem Soc Trans; 2010 Apr; 38(2):364-9. PubMed ID: 20298184
[TBL] [Abstract][Full Text] [Related]
30. Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.
Goldman A; Chen HD; Roesly HB; Hill KA; Tome ME; Dvorak B; Bernstein H; Dvorak K
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G292-302. PubMed ID: 21127259
[TBL] [Abstract][Full Text] [Related]
31. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of nucleostemin upregulates CDX2 expression in HT29 cells in response to bile acid exposure: implications in the pathogenesis of Barrett's esophagus.
Sun YG; Wang XW; Yang SM; Zhou G; Wang WQ; Wang HB; Wang RQ; Fang DC
J Gastrointest Surg; 2009 Aug; 13(8):1430-9. PubMed ID: 19449081
[TBL] [Abstract][Full Text] [Related]
33. In oesophageal squamous cells, nitric oxide causes S-nitrosylation of Akt and blocks SOX2 (sex determining region Y-box 2) expression.
Asanuma K; Huo X; Agoston A; Zhang X; Yu C; Cheng E; Zhang Q; Dunbar KB; Pham TH; Wang DH; Iijima K; Shimosegawa T; Odze RD; Spechler SJ; Souza RF
Gut; 2016 Sep; 65(9):1416-26. PubMed ID: 25986942
[TBL] [Abstract][Full Text] [Related]
34. [Pathogenesis of Barrett's esophagus--new findings in the experimental studies of duodenal reflux models].
Hattori T; Mukaisho K; Miwa K
Nihon Rinsho; 2005 Aug; 63(8):1341-9. PubMed ID: 16101219
[TBL] [Abstract][Full Text] [Related]
35. BMP4 promotes a phenotype change of an esophageal squamous epithelium via up-regulation of KLF4.
Yan W; Zhang H; Li J; Shen C; Xia Y; Wang P; Zhang Y; Feng J; Shao S; Yu X; Fang D
Exp Mol Pathol; 2016 Oct; 101(2):259-266. PubMed ID: 27693253
[TBL] [Abstract][Full Text] [Related]
36. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
37. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
[TBL] [Abstract][Full Text] [Related]
39. [Role of bile acids on Barrett's esophagus].
Kazumori H; Kinoshita Y
Nihon Shokakibyo Gakkai Zasshi; 2007 Jan; 104(1):10-6. PubMed ID: 17230000
[No Abstract] [Full Text] [Related]
40. Omeprazole prevents CDX2 and SOX9 expression by inhibiting hedgehog signaling in Barrett's esophagus cells.
Huang J; Liu H; Sun T; Fang JY; Wang J; Xiong H
Clin Sci (Lond); 2019 Feb; 133(3):483-495. PubMed ID: 30705106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
